Avi Oler | VP, Corporate Development, General Counsel |
Steve Fruchtman | President and CEO |
Ric Woodman | Chief Medical Officer |
Mark Guerin | CFO |
Joseph Pantginis | H.C. Wainwright |
Naureen Quibria | Maxim |
Ahu Demir | Noble Capital Markets |
Yale Jen | Laidlaw & Company |
Good morning, and welcome to the Onconova Therapeutics Corporate Update and First Quarter 2019 Financial Results Conference Call. [Operator Instructions] As a reminder, this call maybe recorded. At this time, I’d like to turn the call over to Avi Oler, Vice President of Corporate Development and General Counsel at Onconova.
Thank you, Operator. Good morning and welcome to Onconova's corporate update and first quarter 2019 corporate update and first quarter financial results conference call.